NB151055

RSV Fusion Protein Antibody (RSHZ19 (Felvizumab)), DyLight 488, Novus Biologicals™

Manufacturer: Novus Biologicals

Select a Size

Pack Size SKU Availability Price
Each of 1 NB151055-Each-of-1 In Stock ₹ 55,271.76

NB151055 - Each of 1

₹ 55,271.76

In Stock

Quantity

1

Base Price: ₹ 55,271.76

GST (18%): ₹ 9,948.917

Total Price: ₹ 65,220.677

Antigen

RSV Fusion Protein

Classification

Monoclonal

Conjugate

DyLight 488

Formulation

50mM Sodium Borate

Immunogen

This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.

Quantity

0.1 mL

Primary or Secondary

Primary

Content And Storage

Store at 4°C in the dark.

Isotype

IgG1 κ

Applications

ELISA

Clone

RSHZ19 (Felvizumab)

Dilution

ELISA

Host Species

Human

Purification Method

Protein A purified

Regulatory Status

RUO

Target Species

Virus

Form

Purified

Description

  • RSV Fusion Protein Monoclonal specifically detects RSV Fusion Protein in Viral samples
  • It is validated for ELISA.

Compare Similar Items

Show Difference

Img

Novus Biologicals

NB151055

--


Antigen:
RSV Fusion Protein

Classification:
Monoclonal

Conjugate:
DyLight 488

Formulation:
50mM Sodium Borate

Immunogen:
This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.

Quantity:
0.1 mL

Primary or Secondary:
Primary

Content And Storage:
Store at 4°C in the dark.

Isotype:
IgG1 κ

Applications:
ELISA

Clone:
RSHZ19 (Felvizumab)

Dilution:
ELISA

Host Species:
Human

Purification Method:
Protein A purified

Regulatory Status:
RUO

Target Species:
Virus

Form:
Purified

Img

Novus Biologicals

NB151058

--


Antigen:
RSV Fusion Protein

Classification:
Monoclonal

Conjugate:
Janelia Fluor 549

Formulation:
50mM Sodium Borate

Immunogen:
This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.

Quantity:
0.1 mL

Primary or Secondary:
Primary

Content And Storage:
Store at 4°C in the dark.

Isotype:
IgG1 κ

Applications:
ELISA

Clone:
RSHZ19 (Felvizumab)

Dilution:
ELISA

Host Species:
Human

Purification Method:
Protein A purified

Regulatory Status:
RUO

Target Species:
Virus

Form:
Purified

Img

Novus Biologicals

NB151059

--


Antigen:
RSV Fusion Protein

Classification:
Monoclonal

Conjugate:
Janelia Fluor 646

Formulation:
50mM Sodium Borate

Immunogen:
This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.

Quantity:
0.1 mL

Primary or Secondary:
Primary

Content And Storage:
Store at 4°C in the dark.

Isotype:
IgG1 κ

Applications:
ELISA

Clone:
RSHZ19 (Felvizumab)

Dilution:
ELISA

Host Species:
Human

Purification Method:
Protein A purified

Regulatory Status:
RUO

Target Species:
Virus

Form:
Purified

Img

Novus Biologicals

NB151062

--


Antigen:
RSV Fusion Protein

Classification:
Monoclonal

Conjugate:
DyLight 405

Formulation:
50mM Sodium Borate

Immunogen:
This antibody was prepared by the humanization of an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework.

Quantity:
0.1 mL

Primary or Secondary:
Primary

Content And Storage:
Store at 4°C in the dark.

Isotype:
IgG1 κ

Applications:
ELISA

Clone:
RSHZ19 (Felvizumab)

Dilution:
ELISA

Host Species:
Human

Purification Method:
Protein A purified

Regulatory Status:
RUO

Target Species:
Virus

Form:
Purified